IIT RESEARCH INSTITUTE
- Unique Entity ID (UEI)
- DGBUFQYMKWB5
- Parent company
- IIT RESEARCH INSTITUTE (this vendor is its own parent)
- Registered address
- CHICAGO, IL, district IL-01
- Other names on record
- I I T RESEARCH INSTITUTE; I I T RESEARCH INSTITUTE INC
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 17, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027
USAspending lists no contract dollars for this vendor in fiscal year 2027 yet.
Fiscal year 2026: $3,215,119.32
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | $3,215,119.32 |
| District where the work is done | Contract dollars |
|---|---|
| IL-01Jonathan L. Jackson | $2,687,397.64 |
| IL-07Danny K. Davis | $527,721.68 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| 75N91022C00010PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-07 | $3,452,984 | Ends March 31, 2027 |
| 75N98026F00001TASK ORDER AWARD- SSL GLP AND NON-GLP TOXICOLOGY STUDIES | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $3,391,980 | Ends December 25, 2027 |
| 75N91018F00005IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED) | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $1,984,675.73 | Ends July 25, 2025 |
| 75N91020F00001TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022 | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $1,161,990.18 | Ends January 31, 2026 |
| 75N95020F00003NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021. | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $751,370.91 | Ends December 31, 2024 |
| 75N91024F00003TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102 | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-07 | $627,793 | Ends October 31, 2026 |
| HHSN26100003IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-07 | $626,265.68 | Ends September 30, 2022 |
| 75N95024F00002FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $547,006 | Ends December 31, 2025 |
| 75N95024F00001IITRI - PERFORMANCE AREA 1 TO2 | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $212,495 | Ends February 28, 2027 |
| 75N98026F00002IITRI - PA1 TASK ORDER #07 | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $108,506 | Ends September 11, 2027 |
| 75N91026F00001TOXICOLOGY STUDIES IN MICE ADMINISTERED MTX-531 - FINAL DELIVERABLES | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $68,323 | Ends May 9, 2026 |
| 75N98026F00003IITRI - 2026 SF IND-ENABLING GLP TOXICOLOGY STUDIES | Department of Health and Human ServicesNational Institutes of Health | CHICAGO, IL-01 | $46,385 | Ends March 14, 2028 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
No subcontract is reported under this vendor’s largest awards.
Lobbying reports and campaign receipts that name this vendor
No lobbying report, organization page or FEC receipt in our saved records has this vendor’s name or its parent company’s name.
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.